NO20054532L - Fremgangsmater for a forhindre glukonoylering av proteiner - Google Patents

Fremgangsmater for a forhindre glukonoylering av proteiner

Info

Publication number
NO20054532L
NO20054532L NO20054532A NO20054532A NO20054532L NO 20054532 L NO20054532 L NO 20054532L NO 20054532 A NO20054532 A NO 20054532A NO 20054532 A NO20054532 A NO 20054532A NO 20054532 L NO20054532 L NO 20054532L
Authority
NO
Norway
Prior art keywords
preventing
gluconeylation
proteins
methods
gluconylation
Prior art date
Application number
NO20054532A
Other languages
English (en)
Other versions
NO20054532D0 (no
Inventor
Alan Gardner
Thomasd Sweitzer
Alexander H Taylor
P Patel
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20054532D0 publication Critical patent/NO20054532D0/no
Publication of NO20054532L publication Critical patent/NO20054532L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

2005-11-24 Sammendrag 0.nr.E41 972 Den foreliggende oppfinnelsen vedrører en fremgangsmåte for å forbygge glukonylering av polypeptider produsert i mikroorganismer.
NO20054532A 2003-03-04 2005-10-03 Fremgangsmater for a forhindre glukonoylering av proteiner NO20054532L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45168603P 2003-03-04 2003-03-04
PCT/US2004/006507 WO2004078936A2 (en) 2003-03-04 2004-03-04 Methods for preventing gluconoylation of proteins

Publications (2)

Publication Number Publication Date
NO20054532D0 NO20054532D0 (no) 2005-10-03
NO20054532L true NO20054532L (no) 2005-11-24

Family

ID=32962626

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054532A NO20054532L (no) 2003-03-04 2005-10-03 Fremgangsmater for a forhindre glukonoylering av proteiner

Country Status (21)

Country Link
US (2) US8173396B2 (no)
EP (1) EP1599578B1 (no)
JP (1) JP2006520609A (no)
KR (2) KR101146483B1 (no)
CN (2) CN1798836B (no)
AR (1) AR043719A1 (no)
AT (1) ATE517985T1 (no)
AU (2) AU2004217491B2 (no)
BR (1) BRPI0408023A (no)
CA (1) CA2517857A1 (no)
ES (1) ES2369359T3 (no)
IS (1) IS8029A (no)
MA (1) MA27744A1 (no)
MX (1) MXPA05009453A (no)
MY (1) MY142798A (no)
NO (1) NO20054532L (no)
NZ (1) NZ570598A (no)
RU (2) RU2005130650A (no)
TW (1) TW200504218A (no)
WO (1) WO2004078936A2 (no)
ZA (1) ZA200506709B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2542391A (en) 2015-09-17 2017-03-22 Annexin Pharmaceuticals Ab Process of manufacture
JP7304380B2 (ja) 2021-04-26 2023-07-06 プライムプラネットエナジー&ソリューションズ株式会社 電極集電体および二次電池
WO2025252176A1 (zh) * 2024-06-05 2025-12-11 杭州明德生物医药技术有限公司 表达载体及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0286239B1 (en) * 1987-03-10 1996-03-13 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
US5643758A (en) * 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
DE4028086A1 (de) * 1990-09-05 1992-03-12 Boehringer Mannheim Gmbh Stabile 6-phosphogluconolactonase, verfahren zu deren gewinnung sowie verwendung des enzyms zur bestimmung
US5733762A (en) * 1994-04-28 1998-03-31 I.D.M. Immuno-Designed Molecules Complexes of nucleic acid and polymer, their process of preparation and their use for the transfection of cells
US5948681A (en) * 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer

Also Published As

Publication number Publication date
CN1798836A (zh) 2006-07-05
MA27744A1 (fr) 2006-02-01
CN101942470A (zh) 2011-01-12
EP1599578B1 (en) 2011-07-27
JP2006520609A (ja) 2006-09-14
KR101146483B1 (ko) 2012-05-24
AU2009201136A1 (en) 2009-04-09
US20120196372A1 (en) 2012-08-02
IS8029A (is) 2005-09-15
ATE517985T1 (de) 2011-08-15
EP1599578A2 (en) 2005-11-30
US8173396B2 (en) 2012-05-08
US20090233333A1 (en) 2009-09-17
NO20054532D0 (no) 2005-10-03
BRPI0408023A (pt) 2006-02-14
TW200504218A (en) 2005-02-01
KR20110134514A (ko) 2011-12-14
ES2369359T3 (es) 2011-11-29
CA2517857A1 (en) 2004-09-16
AU2009201136B2 (en) 2011-06-23
WO2004078936A2 (en) 2004-09-16
KR20050107486A (ko) 2005-11-11
AU2004217491B2 (en) 2009-04-09
AU2004217491A1 (en) 2004-09-16
RU2009149159A (ru) 2011-07-10
MXPA05009453A (es) 2005-11-23
CN1798836B (zh) 2011-04-27
ZA200506709B (en) 2006-08-30
RU2005130650A (ru) 2006-04-10
MY142798A (en) 2010-12-31
WO2004078936A3 (en) 2006-02-16
AR043719A1 (es) 2005-08-10
NZ570598A (en) 2010-03-26
EP1599578A4 (en) 2007-03-14

Similar Documents

Publication Publication Date Title
DE60132978D1 (de) Hybride expression von neisseria proteinen
DE602004006433D1 (de) Pyrrol-substituierte indole als inhibitoren von pai-1
NO20091976L (no) Nye forbindelser
NO20071378L (no) Tiazolo-naftylsyrer.
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
NO20062860L (no) Sammensetning og fremgangsmate for styrking av biologisk tilgjengelighet
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
ATE490253T1 (de) Synthese von 5-substituierten 7-azaindolen und 7- azaindolinen
SI1644484T1 (sl) Avtologne samo-toleranco inducirajoče celice monocitnega izvora in njihova uporaba v farmacevtskihpripravah
BRPI0414463A (pt) ácidos heteroarilbenzofuránicos substituìdos
CY1108221T1 (el) Μεθοδος για την αναπαραγωγη πλευρομουτιλινων
DE10390418D2 (de) Verfahren zur Herstellung von rekombinanten Proteinen in Mikroorganismen
MY138542A (en) Biguanide and dihydrotriazine derivatives
NO20055741D0 (no) Nye kjemiske forbindelser
EA200701293A1 (ru) Терапевтическая композиция фактора роста кератиноцитов
WO2004011605A3 (en) Hybrid protein methods and compositions
WO2004081033A3 (en) Synthesis of proteins by cell-free protein expression
NO20054532L (no) Fremgangsmater for a forhindre glukonoylering av proteiner
ATE522601T1 (de) Varianten von antithrombin iii
EA200701852A1 (ru) Производные аминокислот
DE602005019703D1 (de) Polymorphe von atorvastatin-tert.-butylester und deren verwendung als zwischenprodukte für die herstellung von atorvastatin
AU2003259750A1 (en) Methods and compositions for targeting secretory lysosomes
ATE437846T1 (de) Cyclooct-(en-)yl-derivate zur verwendung als duftstoffe

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application